Inborn defects in the antioxidant systems of human red blood cells

Free Radical Biology and Medicine

Volumn 67, Issue , 2014, Pages 377-386

  Van Zwieten, Rob ^a   Verhoeven, Arthur J ^b   Roos, Dirk ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Erythrocytes; Favism; Free radicals; G6PD deficiency; Glutathione; Hemolytic anemia; Methemoglobin; Oxidative stress; Pentose phosphate pathway; Red blood cells; Sickle cell trait; Thalassemia

Indexed keywords

ANTIOXIDANT; CATALASE; CYTOCHROME B5 REDUCTASE; GLUTATHIONE; HEMOGLOBIN; IRON; METHEMOGLOBIN; METHEMOGLOBIN REDUCTASE; PENTOSE; PEROXIREDOXIN; PHOSPHATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SUPEROXIDE DISMUTASE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; ERYTHROCYTE; GLUTATHIONE METABOLISM; HEMOGLOBINOPATHY; HUMAN; MALARIA; PRIORITY JOURNAL; REGENERATION; THALASSEMIA; TISSUE INJURY; ANTIOXIDANT ACTIVITY; CAPILLARY ENDOTHELIUM; CELL ADHESION; ENZYME ACTIVITY; ERYTHROPOIESIS; GENETIC DISORDER; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GLYCOLYSIS; MACROPHAGE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARASITE; REDUCTION KINETICS; REVIEW; SICKLE CELL TRAIT; SPLEEN; SURVIVAL; THALASSEMIA MINOR; HEMOLYTIC ANEMIA; METABOLISM; PATHOLOGY;

ANEMIA, HEMOLYTIC; ANTIOXIDANTS; ERYTHROCYTES; ERYTHROPOIESIS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; GLUTATHIONE; HUMANS; MALARIA; NADP; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SICKLE CELL TRAIT; THALASSEMIA;

EID: 84891586833     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2013.11.022     Document Type: Review

References (155)

1. E. Beutler Red cell metabolism. A. Defects not causing hemolytic disease. B. Environmental modification Biochimie 54 1972 759 764
2. 2 levels in erythrocytes Free Radic. Biol. Med. 39 2005 1407 1417 (Pubitemid 41547221)
3. K.B. Pandey, and S.I. Rizvi Protective effect of resveratrol on formation of membrane protein carbonyls and lipid peroxidation in erythrocytes subjected to oxidative stress Appl. Physiol. Nutr. Metab. 34 2009 1093 1097
4. L. Gil, W. Siems, B. Mazurek, J. Gross, P. Schroeder, and P. Voss et al. Age-associated analysis of oxidative stress parameters in human plasma and erythrocytes Free Radic. Res. 40 2006 495 505
5. E. Schroder, and C.P. Ponting Evidence that peroxiredoxins are novel members of the thioredoxin fold superfamily Protein Sci. 7 1998 2465 2468 (Pubitemid 28506964)
6. R.M. Johnson, Y.S. Ho, D.Y. Yu, F.A. Kuypers, Y. Ravindranath, and G.W. Goyette The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism Free Radic. Biol. Med. 48 2010 519 525
7. J.M. McCord, and I. Fridovich The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite, dimethyl sulfoxide, and oxygen J. Biol. Chem. 244 1969 6056 6063
8. M.R. Clemens, and H.D. Waller Lipid peroxidation in erythrocytes Chem. Phys. Lipids 45 1987 251 268 (Pubitemid 17152337)
9. J.M. May Ascorbate function and metabolism in the human erythrocyte Front. Biosci. 3 1998 d1 10
10. S. Claster, J.C. Wood, L. Noetzli, S.M. Carson, T.C. Hofstra, and R. Khanna et al. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies Am. J. Hematol. 84 2009 344 348
11. A. Montel-Hagen, S. Kinet, N. Manel, C. Mongellaz, R. Prohaska, and J.L. Battini et al. Erythrocyte Glut1 triggers dehydroascorbic acid uptake in mammals unable to synthesize vitamin C Cell 132 2008 1039 1048 (Pubitemid 351391954)
12. Q.H. Gibson, and D.C. Harrison The ratios of iron to oxygen, iron to colour and oxygen to colour in the blood of men and women J. Physiol. 105 1946 1
13. M.J. Percy, and T.R. Lappin Recessive congenital methaemoglobinaemia: cytochrome b(5) reductase deficiency Br. J. Haematol. 141 2008 298 308 (Pubitemid 351521146)
14. R.S. Richards, T.K. Roberts, R.H. Dunstan, N.R. McGregor, and H.L. Butt Erythrocyte antioxidant systems protect cultured endothelial cells against oxidant damage Biochem. Mol. Biol. Int. 46 1998 857 865 (Pubitemid 29004596)
15. A.E. Tsantes, S. Bonovas, A. Travlou, and N.M. Sitaras Redox imbalance, macrocytosis, and RBC homeostasis Antioxid. Redox Signaling 8 2006 1205 1216 (Pubitemid 44182419)
16. C.D. Reiter, X. Wang, J.E. Tanus-Santos, N. Hogg, R.O. Cannon III, and A.N. Schechter et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease Nat. Med. 8 2002 1383 1389 (Pubitemid 36019423)
17. Y. Ogasawara, M. Funakoshi, and K. Ishii Glucose metabolism is accelerated by exposure to t-butylhydroperoxide during NADH consumption in human erythrocytes Blood Cells Mol. Dis. 41 2008 237 243
18. M. Bianchi, and M. Magnani Hexokinase mutations that produce nonspherocytic hemolytic anemia Blood Cells Mol. Dis. 21 1995 2 8
19. H. Kanno, K. Murakami, Y. Hariyama, K. Ishikawa, S. Miwa, and H. Fujii Homozygous intragenic deletion of type I hexokinase gene causes lethal hemolytic anemia of the affected fetus Blood 100 2002 1930 (Pubitemid 34925182)
20. F. Climent, F. Roset, A. Repiso, and P. Perez de la Ossa Red cell glycolytic enzyme disorders caused by mutations: an update Cardiovasc. Hematol. Disord. Drug Targets 9 2009 95 106
21. A. Kinoshita, Y. Nakayama, T. Kitayama, and M. Tomita Simulation study of methemoglobin reduction in erythrocytes: differential contributions of two pathways to tolerance to oxidative stress FEBS J. 274 2007 1449 1458 (Pubitemid 46333737)
22. A. Zanella, E. Fermo, P. Bianchi, L.R. Chiarelli, and G. Valentini Pyruvate kinase deficiency: the genotype-phenotype association Blood Rev. 21 2007 217 231 (Pubitemid 46887628)
23. R. van Wijk, E.G. Huizinga, A.C. van Wesel, B.A. van Oirschot, M.A. Hadders, and W.W. van Solinge Fifteen novel mutations in PKLR associated with pyruvate kinase (PK) deficiency: structural implications of amino acid substitutions in PK Hum. Mutat. 30 2009 446 453
24. K.R. Tanaka, and D.E. Paglia Pyruvate kinase deficiency Semin. Hematol. 8 1971 367 396
25. A. Tomoda, N.A. Lachant, N.A. Noble, and K.R. Tanaka Inhibition of the pentose phosphate shunt by 2,3-diphosphoglycerate in erythrocyte pyruvate kinase deficiency Br. J. Haematol. 54 1983 475 484 (Pubitemid 13054569)
26. W.D. Davidson, and K.R. Tanaka Factors affecting pentose phosphate pathway activity in human red cells Br. J. Haematol. 23 1972 371 385
27. S. Chung, D.K. Arrell, R.S. Faustino, A. Terzic, and P.P. Dzeja Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation J. Mol. Cell. Cardiol. 48 2010 725 734
28. J.H. Huck, N.M. Verhoeven, E.A. Struys, G.S. Salomons, C. Jakobs, and M.S. van der Knaap Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy Am. J. Hum. Genet. 74 2004 745 751 (Pubitemid 38420104)
29. A. Perl The pathogenesis of transaldolase deficiency IUBMB Life 59 2007 365 373 (Pubitemid 47027116)
30. M.M. Wamelink, E.A. Struys, and C. Jakobs The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review J. Inherit. Metab. Dis. 31 2008 703 717
31. G.J. Brewer, and R.J. Dern A new inherited enzymatic deficiency of human erythrocytes: 6-phosphogluconate dehydrogenase deficiency Am. J. Hum. Genet. 16 1964 472 476
32. C.W. Parr, and L.I. Fitch Inherited quantitative variations of human phosphogluconate dehydrogenase Ann. Hum. Genet. 30 1967 339 353
33. J.L. Vives Corrons, D. Colomer, A. Pujades, A. Rovira, M. Aymerich, and A. Merino et al. Congenital 6-phosphogluconate dehydrogenase (6PGD) deficiency associated with chronic hemolytic anemia in a Spanish family Am. J. Hematol. 53 1996 221 227 (Pubitemid 26419707)
34. P. Caprari, M.P. Caforio, P. Cianciulli, D. Maffi, M.T. Pasquino, and A. Tarzia et al. 6-Phosphogluconate dehydrogenase deficiency in an Italian family Ann. Hematol. 80 2001 41 44 (Pubitemid 32156763)
35. E. Beutler, W. Kuhl, and T. Gelbart 6-Phosphogluconolactonase deficiency, a hereditary erythrocyte enzyme deficiency: possible interaction with glucose-6-phosphate dehydrogenase deficiency Proc. Natl. Acad. Sci. USA 82 1985 3876 3878 (Pubitemid 15246455)
36. E. Beutler, R. Lisker, and W. Kuhl Molecular biology of G 6 PD variants Biomed. Biochim. Acta 49 1990 S236 S241
37. F. Paglialunga, A. Fico, I. Iaccarino, R. Notaro, L. Luzzatto, and G. Martini et al. G6PD is indispensable for erythropoiesis after the embryonic-adult hemoglobin switch Blood 104 2004 3148 3152 (Pubitemid 39507128)
38. L. Bernini, B. Latte, M. Siniscalco, S. Piomelli, U. Spada, and M. Adinolfi et al. Survival of 51Cr-labelled red cells in subjects with thalassemia-trait or G6PD deficiency or both abnormalities Br. J. Haematol. 10 1964 171 180
39. F.E. Boas, L. Forman, and E. Beutler Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia Proc. Natl. Acad. Sci. USA 95 1998 3077 3081 (Pubitemid 28135857)
40. N. Gurbuz, O. Yalcin, T.A. Aksu, and O.K. Baskurt The relationship between the enzyme activity, lipid peroxidation and red blood cells deformability in hemizygous and heterozygous glucose-6-phosphate dehydrogenase deficient individuals Clin. Hemorheol. Microcirc. 31 2004 235 242 (Pubitemid 39362724)
41. M.A. Baker, A. Bosia, G. Pescarmona, F. Turrini, and P. Arese Mechanism of action of divicine in a cell-free system and in glucose-6-phosphate dehydrogenase-deficient red cells Toxicol. Pathol. 12 1984 331 336 (Pubitemid 15100116)
42. L. Luzzatto Glucose 6-phosphate dehydrogenase deficiency: from genotype to phenotype Haematologica 91 2006 1303 1306 (Pubitemid 44574287)
43. G.F. Gaetani, M. Rolfo, S. Arena, R. Mangerini, G.F. Meloni, and A.M. Ferraris Active involvement of catalase during hemolytic crises of favism Blood 88 1996 1084 1088 (Pubitemid 26333335)
44. H.N. Kirkman, and G.F. Gaetani Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH Proc. Natl. Acad. Sci. USA 81 1984 4343 4347 (Pubitemid 14052441)
45. M. Kaplan, P. Renbaum, E. Levy-Lahad, C. Hammerman, A. Lahad, and E. Beutler Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia Proc. Natl. Acad. Sci. USA 94 1997 12128 12132 (Pubitemid 27467854)
46. E. Beutler G6PD deficiency Blood 84 1994 3613 3636 (Pubitemid 24362456)
47. M.R. Cooper, L.R. DeChatelet, C.E. McCall, M.F. LaVia, C.L. Spurr, and R.L. Baehner Complete deficiency of leukocyte glucose-6-phosphate dehydrogenase with defective bactericidal activity J. Clin. Invest. 51 1972 769 778
48. G.R. Gray, G. Stamatoyannopoulos, S.C. Naiman, M.R. Kliman, S.J. Klebanoff, and T. Austin et al. Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase Lancet 2 1973 530 534
49. J.L. Vives Corrons, E. Feliu, M.A. Pujades, F. Cardellach, C. Rozman, and A. Carreras et al. Severe-glucose-6-phosphate dehydrogenase (G6PD) deficiency associated with chronic hemolytic anemia, granulocyte dysfunction, and increased susceptibility to infections: description of a new molecular variant (G6PD Barcelona) Blood 59 1982 428 434 (Pubitemid 12172036)
50. D. Roos, R. van Zwieten, J.T. Wijnen, F. Gomez-Gallego, M. de Boer, and D. Stevens et al. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase Volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections Blood 94 1999 2955 2962 (Pubitemid 29512698)
51. R. van Bruggen, J.M. Bautista, T. Petropoulou, M. de Boer, R. van Zwieten, and F. Gomez-Gallego et al. Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections Blood 100 2002 1026 1030 (Pubitemid 34832633)
52. L.R. Chiarelli, E. Fermo, A. Zanella, and G. Valentini Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview Hematology 11 2006 67 72 (Pubitemid 43354965)
53. A. Zanella, P. Bianchi, E. Fermo, and G. Valentini Hereditary pyrimidine 5'-nucleotidase deficiency: from genetics to clinical manifestations Br. J. Haematol. 133 2006 113 123
54. A. Tomoda, N.A. Noble, N.A. Lachant, and K.R. Tanaka Hemolytic anemia in hereditary pyrimidine 5'-nucleotidase deficiency: nucleotide inhibition of G6PD and the pentose phosphate shunt Blood 60 1982 1212 1218 (Pubitemid 13242305)
55. D.C. Rees, J. Duley, H.A. Simmonds, B. Wonke, S.L. Thein, and J.B. Clegg et al. Interaction of hemoglobin E and pyrimidine 5' nucleotidase deficiency Blood 88 1996 2761 2767 (Pubitemid 26327531)
56. M.D. Cappellini, and G. Fiorelli Glucose-6-phosphate dehydrogenase deficiency Lancet 371 2008 64 74
57. I. Youngster, L. Arcavi, R. Schechmaster, Y. Akayzen, H. Popliski, and J. Shimonov et al. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review Drug Saf. 33 2010 713 726
58. D. Roos, C.M. Eckmann, M. Yazdanbakhsh, M.N. Hamers, and M. de Boer Excretion of superoxide by phagocytes measured with cytochrome c entrapped in resealed erythrocyte ghosts J. Biol. Chem. 259 1984 1770 1775 (Pubitemid 14146565)
59. T. Kanias, and J.P. Acker Biopreservation of red blood cells - the struggle with hemoglobin oxidation FEBS J. 277 2010 343 356
60. M.T. Gladwin Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation Adv. Exp. Med. Biol. 588 2006 189 205
61. K.S. Lang, C. Duranton, H. Poehlmann, S. Myssina, C. Bauer, and F. Lang et al. Cation channels trigger apoptotic death of erythrocytes Cell Death Differ. 10 2003 249 256 (Pubitemid 36553467)
62. J.M. Rifkind, and E. Nagababu Hemoglobin redox reactions and red blood cell aging Antioxid. Redox Signaling 18 2013 2274 2283
63. P. Burger, P. Hilarius-Stokman, D. de Korte, T.K. van den Berg, and R. van Bruggen CD47 functions as a molecular switch for erythrocyte phagocytosis Blood 119 2012 5512 5521
64. C. Donadee, N.J. Raat, T. Kanias, J. Tejero, J.S. Lee, and E.E. Kelley et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion Circulation 124 2011 465 476
65. A. So, and B. Thorens Uric acid transport and disease J. Clin. Invest. 120 2010 1791 1799
66. P.C. Minneci, K.J. Deans, H. Zhi, P.S. Yuen, R.A. Star, and S.M. Banks et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin J. Clin. Invest. 115 2005 3409 3417 (Pubitemid 43121829)
67. P. Wardman, and L.P. Candeias Fenton chemistry: an introduction Radiat. Res. 145 1996 523 531 (Pubitemid 26127159)
68. M.T. Gladwin, T. Kanias, and D.B. Kim-Shapiro Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease J. Clin. Invest 122 2012 1205 1208
69. O. Borst, M. Abed, I. Alesutan, S.T. Towhid, S.M. Qadri, and M. Foller et al. Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX Am. J. Physiol. Cell Physiol. 302 2012 C644 C651
70. F. Johnson, and C. Giulivi Superoxide dismutases and their impact upon human health Mol. Aspects Med. 26 2005 340 352 (Pubitemid 41225357)
71. A. Grzelak, M. Kruszewski, E. Macierzynska, L. Piotrowski, L. Pulaski, and B. Rychlik et al. The effects of superoxide dismutase knockout on the oxidative stress parameters and survival of mouse erythrocytes Cell. Mol. Biol. Lett. 14 2009 23 34
72. G. Cohen, and P. Hochstein Glutathione peroxidase: the primary agents for the elimination of hydrogen peroxide in erythrocytes Biochemistry 2 1963 1420 1428
73. S. Takahara Progressive oral gangrene probably due to lack of catalase in the blood (acatalasaemia); report of nine cases Lancet 2 1952 1101 1104
74. L. Goth, P. Rass, and A. Pay Catalase enzyme mutations and their association with diseases Mol. Diagn. 8 2004 141 149 (Pubitemid 40468779)
75. Y.S. Ho, Y. Xiong, W. Ma, A. Spector, and D.S. Ho Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury J. Biol. Chem. 279 2004 32804 32812 (Pubitemid 39014740)
76. Y. Ogasawara, T. Ohminato, Y. Nakamura, and K. Ishii Structural and functional analysis of native peroxiredoxin 2 in human red blood cells Int. J. Biochem. Cell Biol. 44 2012 1072 1077
77. F.M. Low, M.B. Hampton, and C.C. Winterbourn Peroxiredoxin 2 and peroxide metabolism in the erythrocyte Antioxid. Redox Signaling 10 2008 1621 16230
78. T.H. Lee, S.U. Kim, S.L. Yu, S.H. Kim, D.S. Park, and H.B. Moon et al. Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice Blood 101 2003 5033 5038 (Pubitemid 36857770)
79. K.M. Stuhlmeier, J.J. Kao, P. Wallbrandt, M. Lindberg, B. Hammarstrom, and H. Broell et al. Antioxidant protein 2 prevents methemoglobin formation in erythrocyte hemolysates Eur. J. Biochem. 270 2003 334 341 (Pubitemid 36114931)
80. E. Beutler, J.T. Curnutte, and L. Forman Glutathione peroxidase deficiency and childhood seizures Lancet 338 1991 700
81. H.K. Prins, M. Oort, C. Zurcher, and T. Beckers Congenital nonspherocytic hemolytic anemia, associated with glutathione deficiency of the erythrocytes: hematologic, biochemical and genetic studies Blood 27 1966 145 166
82. E. Ristoff, C. Augustson, J. Geissler, T. de Rijk, K. Carlsson, and J.L. Luo et al. A missense mutation in the heavy subunit of gamma-glutamylcysteine synthetase gene causes hemolytic anemia Blood 95 2000 2193 2196
83. D. Hamilton, J.H. Wu, M. Alaoui-Jamali, and G. Batist A novel missense mutation in the gamma-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production Blood 102 2003 725 730 (Pubitemid 36841998)
84. E. Beutler, T. Gelbart, T. Kondo, and A.T. Matsunaga The molecular basis of a case of gamma-glutamylcysteine synthetase deficiency Blood 94 1999 2890 2894 (Pubitemid 29477318)
85. P.M. Manu, T. Gelbart, E. Ristoff, K.C. Crain, J.M. Bergua, and L.A. Lopez et al. Chronic non-spherocytic hemolytic anemia associated with severe neurological disease due to gamma-glutamylcysteine synthetase deficiency in a patient of Moroccan origin Haematologica 92 2007 e102 e105
86. T.M. Le, A.S. Willis, F.E. Barr, G.R. Cunningham, J.A. Canter, and S.E. Owens et al. An ethnic-specific polymorphism in the catalytic subunit of glutamate-cysteine ligase impairs the production of glutathione intermediates in vitro Mol. Genet. Metab. 101 2010 55 61
87. A.C. Walsh, J.A. Feulner, and A. Reilly Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: association with glutathione levels and drug resistance in the National Cancer Institute tumor cell line panel Toxicol. Sci. 61 2001 218 223 (Pubitemid 32499389)
88. N. Dahl, M. Pigg, E. Ristoff, R. Gali, B. Carlsson, and B. Mannervik et al. Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction Hum. Mol. Genet. 6 1997 1147 1152 (Pubitemid 27308401)
89. Z.Z. Shi, G.M. Habib, W.J. Rhead, W.A. Gahl, X. He, and S. Sazer et al. Mutations in the glutathione synthetase gene cause 5-oxoprolinuria Nat. Genet. 14 1996 361 365
90. R. Njalsson, K. Carlsson, A. Winkler, A. Larsson, and S. Norgren Diagnostics in patients with glutathione synthetase deficiency but without mutations in the exons of the GSS gene Hum. Mutat. 22 2003 497
91. R. Njalsson, E. Ristoff, K. Carlsson, A. Winkler, A. Larsson, and S. Norgren Genotype, enzyme activity, glutathione level, and clinical phenotype in patients with glutathione synthetase deficiency Hum. Genet. 116 2005 384 389 (Pubitemid 40521115)
92. E. Ristoff, C. Hebert, R. Njalsson, S. Norgren, O. Rooyackers, and A. Larsson Glutathione synthetase deficiency: is gamma-glutamylcysteine accumulation a way to cope with oxidative stress in cells with insufficient levels of glutathione? J. Inherit. Metab. Dis. 25 2002 577 584 (Pubitemid 36266993)
93. E. Simon, M. Vogel, R. Fingerhut, E. Ristoff, E. Mayatepek, and U. Spiekerkotter Diagnosis of glutathione synthetase deficiency in newborn screening J. Inherit. Metab. Dis. 32 Suppl. 1 2009 269 272
94. E. Ristoff, E. Mayatepek, and A. Larsson Long-term clinical outcome in patients with glutathione synthetase deficiency J. Pediatr. 139 2001 79 84 (Pubitemid 32613991)
95. N. Makino, and Y. Sugita The structure of partially oxygenated hemoglobin: a highly reactive intermediate toward a sulfhydryl titrant J. Biol. Chem. 257 1982 163 168 (Pubitemid 12109767)
96. W.N. Valentine, J.I. Toohey, D.E. Paglia, M. Nakatani, and R.A. Brockway Modification of erythrocyte enzyme activities by persulfides and methanethiol: possible regulatory role Proc. Natl. Acad. Sci. USA 84 1987 1394 1398 (Pubitemid 17027360)
97. L.M. Snyder, N.L. Fortier, L. Leb, J. McKenney, J. Trainor, and H. Sheerin et al. The role of membrane protein sulfhydryl groups in hydrogen peroxide-mediated membrane damage in human erythrocytes Biochim. Biophys. Acta 937 1988 229 240 (Pubitemid 18028772)
98. E. Beutler, D. Dunning, I.B. Dabe, and L. Forman Erythrocyte glutathione S-transferase deficiency and hemolytic anemia Blood 72 1988 73 77
99. G.E. Schulz, R.H. Schirmer, and E.F. Pai FAD-binding site of glutathione reductase J. Mol. Biol. 160 1982 287 308 (Pubitemid 13239303)
100. F. Rohner, M.B. Zimmermann, R. Wegmueller, A.B. Tschannen, and R.F. Hurrell Mild riboflavin deficiency is highly prevalent in school-age children but does not increase risk for anaemia in Cote d'Ivoire Br. J. Nutr. 97 2007 970 976 (Pubitemid 46554412)
101. B.B. Anderson, L. Corda, G.M. Perry, D. Pilato, M. Giuberti, and C. Vullo Deficiency of two red-cell flavin enzymes in a population in Sardinia: was glutathione reductase deficiency specifically selected for by malaria? Am. J. Hum. Genet. 57 1995 674 681
102. B.S. Das, D.B. Das, R.N. Satpathy, J.K. Patnaik, and T.K. Bose Riboflavin deficiency and severity of malaria Eur. J. Clin. Nutr. 42 1988 277 283
103. V. Gallo, E. Schwarzer, S. Rahlfs, R.H. Schirmer, R. van Zwieten, and D. Roos et al. Inherited glutathione reductase deficiency and Plasmodium falciparum malaria - a case study PLoS One 4 2009 e7303
104. H. Loos, D. Roos, R. Weening, and J. Houwerzijl Familial deficiency of glutathione reductase in human blood cells Blood 48 1976 53 62
105. N.M. Kamerbeek, R. van Zwieten, M. de Boer, G. Morren, H. Vuil, and N. Bannink et al. Molecular basis of glutathione reductase deficiency in human blood cells Blood 109 2007 3560 3566 (Pubitemid 46572550)
106. S.M. Kanzok, R.H. Schirmer, I. Turbachova, R. Iozef, and K. Becker The thioredoxin system of the malaria parasite Plasmodium falciparum: glutathione reduction revisited J. Biol. Chem. 275 2000 40180 40186 (Pubitemid 32064647)
107. E. Ristoff, and A. Larsson Inborn errors in the metabolism of glutathione Orphanet J. Rare Dis. 2 2007 16
108. T.P. Dalton, Y. Chen, S.N. Schneider, D.W. Nebert, and H.G. Shertzer Genetically altered mice to evaluate glutathione homeostasis in health and disease Free Radic. Biol. Med. 37 2004 1511 1526 (Pubitemid 39349798)
109. L.K. Rogers, T. Tamura, B.J. Rogers, S.E. Welty, T.N. Hansen, and C.V. Smith Analyses of glutathione reductase hypomorphic mice indicate a genetic knockout Toxicol. Sci. 82 2004 367 373 (Pubitemid 39600063)
110. R.O. Wright, W.J. Lewander, and A.D. Woolf Methemoglobinemia: etiology, pharmacology, and clinical management Ann. Emerg. Med. 34 1999 646 656 (Pubitemid 29510918)
111. E.R. Jaffe Enzymopenic hereditary methemoglobinemia: a clinical/biochemical classification Blood Cells 12 1986 81 90 (Pubitemid 17056716)
112. J. Dekker, M.H. Eppink, R. van Zwieten, T. de Rijk, A.F. Remacha, and L.K. Law et al. Seven new mutations in the nicotinamide adenine dinucleotide reduced-cytochrome b(5) reductase gene leading to methemoglobinemia type I Blood 97 2001 1106 1114 (Pubitemid 32154300)
113. G. Stamatoyannopoulos, P.E. Nute, E. Giblett, J. Detter, and R. Chard Haemoglobin M Hyde Park occurring as a fresh mutation: diagnostic, structural, and genetic considerations J. Med. Genet. 13 1976 142 147
114. J.C. Goldsmith, V.L. Bonham, C.H. Joiner, G.J. Kato, A.S. Noonan, and M.H. Steinberg Framing the research agenda for sickle cell trait: building on the current understanding of clinical events and their potential implications Am. J. Hematol. 87 2012 340 346
115. S. Rivella The role of ineffective erythropoiesis in non-transfusion- dependent thalassemia Blood Rev. 26 Suppl. 1 2012 S12 S15
116. Y. Ginzburg, and S. Rivella beta-Thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism Blood 118 2011 4321 4330
117. M. Aslan, and B.A. Freeman Redox-dependent impairment of vascular function in sickle cell disease Free Radic. Biol. Med. 43 2007 1469 1483 (Pubitemid 47615401)
118. N. Conran, and F.F. Costa Hemoglobin disorders and endothelial cell interactions Clin. Biochem. 42 2009 1824 1838
119. O. Boutaud, K.P. Moore, B.J. Reeder, D. Harry, A.J. Howie, and S. Wang et al. Acetaminophen inhibits hemoprotein-catalyzed lipid peroxidation and attenuates rhabdomyolysis-induced renal failure Proc. Natl. Acad. Sci. USA 107 2010 2699 2704
120. A. Allen, C. Fisher, A. Premawardhena, D. Bandara, A. Perera, and S. Allen et al. Methemoglobinemia and ascorbate deficiency in hemoglobin E beta thalassemia: metabolic and clinical implications Blood 120 2012 2939 2944
121. Y. Niihara, N.M. Matsui, Y.M. Shen, D.A. Akiyama, C.S. Johnson, and M.A. Sunga et al. L-glutamine therapy reduces endothelial adhesion of sickle red blood cells to human umbilical vein endothelial cells BMC Blood Disord. 5 2005 4
122. C.R. Morris, J.H. Suh, W. Hagar, S. Larkin, D.A. Bland, and M.H. Steinberg et al. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease Blood 111 2008 402 410
123. E. Nur, D.P. Brandjes, T. Teerlink, H.M. Otten, R.P. Oude Elferink, and F. Muskiet et al. N-acetylcysteine reduces oxidative stress in sickle cell patients Ann. Hematol. 91 2012 1097 1105
124. E. Fibach, and E.A. Rachmilewitz The role of antioxidants and iron chelators in the treatment of oxidative stress in thalassemia Ann. N. Y. Acad. Sci. 1202 2010 10 16
125. L. Tesoriere, D. D'Arpa, D. Butera, M. Allegra, D. Renda, and A. Maggio et al. Oral supplements of vitamin E improve measures of oxidative stress in plasma and reduce oxidative damage to LDL and erythrocytes in beta-thalassemia intermedia patients Free Radic. Res. 34 2001 529 540 (Pubitemid 32492691)
126. O. Giardini, A. Cantani, A. Donfrancesco, F. Martino, O. Mannarino, and P. D'Eufemia et al. Biochemical and clinical effects of vitamin E administration in homozygous beta-thalassemia Acta Vitaminol. Enzymol. 7 1985 55 60 (Pubitemid 15010749)
127. M. Karimi, F. Mohammadi, F. Behmanesh, S.M. Samani, M. Borzouee, and H. Amoozgar et al. Effect of combination therapy of hydroxyurea with l-carnitine and magnesium chloride on hematologic parameters and cardiac function of patients with beta-thalassemia intermedia Eur. J. Haematol. 84 2010 52 58
128. B. Toptas, A. Baykal, A. Yesilipek, M. Isbir, A. Kupesiz, and O. Yalcin et al. L-carnitine deficiency and red blood cell mechanical impairment in beta-thalassemia major Clin. Hemorheol. Microcirc. 35 2006 349 357 (Pubitemid 44221941)
129. M.H. Steinberg, M.S. West, D. Gallagher, and W. Mentzer Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia Blood 71 1988 748 752
130. J.M. Flanagan, D.M. Frohlich, T.A. Howard, W.H. Schultz, C. Driscoll, and R. Nagasubramanian et al. Genetic predictors for stroke in children with sickle cell anemia Blood 117 2011 6681 6684
131. M. Magnani, V. Stocchi, F. Canestrari, L. Cucchiarini, O. Stocchi, and G.V. Coppa et al. Redox and energetic state of red blood cells in G6PD deficiency, heterozygous beta-thalassemia and the combination of both Acta Haematol. 75 1986 211 214 (Pubitemid 17184144)
132. H.F. Bunn The triumph of good over evil: protection by the sickle gene against malaria Blood 121 2013 20 25
133. S.K. Das, and R.C. Nair Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes Br. J. Haematol. 44 1980 87 92 (Pubitemid 10201711)
134. S.K. Jain, and S.B. Shohet A novel phospholipid in irreversibly sickled cells: evidence for in vivo peroxidative membrane damage in sickle cell disease Blood 63 1984 362 367 (Pubitemid 14188883)
135. R.P. Hebbel, and W.J. Miller Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia Blood 64 1984 733 741 (Pubitemid 14073496)
136. B.H. Rank, J. Carlsson, and R.P. Hebbel Abnormal redox status of membrane-protein thiols in sickle erythrocytes J. Clin. Invest. 75 1985 1531 1537 (Pubitemid 15041445)
137. S.A. Kuross, B.H. Rank, and R.P. Hebbel Excess heme in sickle erythrocyte inside-out membranes: possible role in thiol oxidation Blood 71 1988 876 882
138. R.P. Hebbel Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology Blood 77 1991 214 237
139. M.J. Griffiths, F. Ndungu, K.L. Baird, D.P. Muller, K. Marsh, and C.R. Newton Oxidative stress and erythrocyte damage in Kenyan children with severe Plasmodium falciparum malaria Br. J. Haematol. 113 2001 486 491 (Pubitemid 32523160)
140. L. Luzzatto, E.S. Nwachuku-Jarrett, and S. Reddy Increased sickling of parasitised erythrocytes as mechanism of resistance against malaria in the sickle-cell trait Lancet 1 1970 319 321
141. E.F. Roth Jr., M. Friedman, Y. Ueda, I. Tellez, W. Trager, and R.L. Nagel Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria Science 202 1978 650 652 (Pubitemid 9055627)
142. M.J. Friedman Oxidant damage mediates variant red cell resistance to malaria Nature 280 1979 245 247 (Pubitemid 9227919)
143. P. Arese, F. Turrini, and E. Schwarzer Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes Cell. Physiol. Biochem. 16 2005 133 146 (Pubitemid 41643014)
144. A. Ferreira, I. Marguti, I. Bechmann, V. Jeney, A. Chora, and N.R. Palha et al. Sickle hemoglobin confers tolerance to Plasmodium infection Cell 145 2011 398 409
145. M.S. Hanson, B. Piknova, A. Keszler, A.R. Diers, X. Wang, and M.T. Gladwin et al. Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction Br. J. Haematol. 154 2011 502 511
146. A. Paine, B. Eiz-Vesper, R. Blasczyk, and S. Immenschuh Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential Biochem. Pharmacol. 80 2010 1895 1903
147. S.W. Ryter, J. Alam, and A.M. Choi Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications Physiol. Rev. 86 2006 583 650
148. D.I. Baruch, B.L. Pasloske, H.B. Singh, X. Bi, X.C. Ma, and M. Feldman et al. Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes Cell 82 1995 77 87
149. R.M. Fairhurst, C.D. Bess, and M.A. Krause Abnormal PfEMP1/knob display on Plasmodium falciparum-infected erythrocytes containing hemoglobin variants: fresh insights into malaria pathogenesis and protection Microbes Infect. 14 2012 851 862
150. S.A. Luse, and L.H. Miller Plasmodium falciparum malaria: ultrastructure of parasitized erythrocytes in cardiac vessels Am. J. Trop. Med. Hyg. 20 1971 655 660
151. R. Cholera, N.J. Brittain, M.R. Gillrie, T.M. Lopera-Mesa, S.A. Diakite, and T. Arie et al. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin Proc. Natl. Acad. Sci. USA 105 2008 991 996 (Pubitemid 351282069)
152. R.M. Fairhurst, D.I. Baruch, N.J. Brittain, G.R. Ostera, J.S. Wallach, and H.L. Hoang et al. Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria Nature 435 2005 1117 1121 (Pubitemid 40910520)
153. M.A. Krause, S.A. Diakite, T.M. Lopera-Mesa, C. Amaratunga, T. Arie, and K. Traore et al. alpha-Thalassemia impairs the cytoadherence of Plasmodium falciparum-infected erythrocytes PLoS One 7 2012 e37214
154. G. LaMonte, N. Philip, J. Reardon, J.R. Lacsina, W. Majoros, and L. Chapman et al. Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance Cell Host Microbe 12 2012 187 199
155. P. Burger, H. Korsten, D. De Korte, E. Rombout, R. Van Bruggen, and A.J. Verhoeven An improved red blood cell additive solution maintains 2,3-diphosphoglycerate and adenosine triphosphate levels by an enhancing effect on phosphofructokinase activity during cold storage Transfusion 50 2010 2386 2392